ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
Subscribe To Our Newsletter & Stay Updated